Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.

What symbol and exchange does Supernus shares trade?

Supernus trades on the NASDAQ stock market under the symbol SUPN.

What is Supernus stock price doing today?

As of November 5, 2026, SUPN stock price climbed to $28.50 with 84,691 million shares trading.

What is Supernus's Beta?

SUPN has a beta of 0.94, meaning it tends to be less sensitive to market movements. SUPN has a correlation of 0.10 to the broad based SPY ETF.

How much is Supernus worth?

SUPN has a market cap of $1.66 billion. This is considered a Small Cap stock.

How much money does Supernus make?

Last quarter Supernus reported $227 million in Revenue and $.35 earnings per share. This beat revenue expectation by $8 million and missed earnings estimates by -$.11.

What is the highest and lowest price Supernus traded in the last 3 year period?

In the last 3 years, SUPN traded as high as $59.68 and as low as $23.05.

What are the top ETFs holding Supernus?

The top ETF exchange traded funds that SUPN belongs to (by Net Assets): IJR, IWM, VTI, SPSM, VB.

Is Supernus (SUPN) a good investment?

SUPN has underperformed the market in the last year with a price return of -35.7% while the SPY ETF gained +14.0%. SUPN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.3% and -11.1%, respectively, while the SPY returned -0.9% and -1.4%, respectively.

What are the support and resistance levels for Supernus (SUPN)?

SUPN support price is $27.38 and resistance is $29.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SUPN shares will trade within this expected range on the day.